UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The impact of short daily and nocturnal hemodialysis on quality of life, cardiovascular risk and survival

Journal of nephrology, 2011-07, Vol.24 (4), p.405-415

2011

Volltextzugriff (PDF)

Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer

Breast cancer research and treatment, 2006-11, Vol.100 (1), p.77-82

2006

Volltextzugriff (PDF)

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

Annals of oncology, 2010-05, Vol.21 (5), p.968-973

2010

Volltextzugriff (PDF)

Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

The New England journal of medicine, 2006-02, Vol.354 (8), p.809-820

2006

Volltextzugriff (PDF)

Two haemodialysis patients with epoetin alfa-induced pure red-cell aplasia recovered despite treatment with another epoetin preparation

Nephrology, dialysis, transplantation, 2004-05, Vol.19 (5), p.1313-1316

2004

Volltextzugriff (PDF)

Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial

Annals of oncology, 2009-03, Vol.20 (3), p.595-596

2009

Volltextzugriff (PDF)

S24 Update of the FINHER trial based on 5 years of follow-up

Breast (Edinburgh), 2009, Vol.18, p.S10-S10

2009

Volltextzugriff (PDF)

A diver unconscious after gastroenteritis

The Lancet (British edition), 1995-11, Vol.346 (8986), p.1338-1338

Asola, M.R.

1995

Volltextzugriff (PDF)

Amino acid uptake in the skeletal muscle measured using [11C]methylaminoisobutyrate (MEAIB) and PET

European journal of nuclear medicine and molecular imaging, 2002-11, Vol.29 (11), p.1485-1491

2002

Volltextzugriff (PDF)

Epirubicin/docetaxel regimen in progressive breast cancer—a phase II study

Anti-cancer drugs, 2002-10, Vol.13 (9), p.925-929

2002

Volltextzugriff (PDF)

Triweekly docetaxel versus biweekly docetaxel as a treatment for advanced castration resistant prostate cancer: Quality of life analysis

JOURNAL OF CLINICAL ONCOLOGY, 2014, Vol.32 (4_suppl), p.23-23

2014

Volltextzugriff (PDF)

4019 POSTER Phase III, randomized, open-label study of triweekly docetaxel (tT) vs. biweekly docetaxel (bT) as treatment for advanced hormone refractory prostate cancer (HRPC): findings from an interim safety analysis

European journal of cancer supplements, 2007, Vol.5 (4), p.285-285

2007

Volltextzugriff (PDF)

Phase III, randomized, open-label study of triweekly docetaxel versus biweekly docetaxel as treatments for advanced hormone-refractory prostate cancer: Findings from an interim safety analysis of the Finnish Uro-oncological Group Study 1-2003

Journal of clinical oncology, 2011-03, Vol.29 (7_suppl), p.129-129

2011

Volltextzugriff (PDF)

Delayed diagnosis and large size of breast cancer after a false negative mammogram

European journal of cancer (1990), 1994, Vol.30 (9), p.1299-1302

1994

Volltextzugriff (PDF)

Significant improvement in recurrence-free survival (RFS) when capecitabine (X) is integrated into docetaxel (T) → 5-FU + epirubicin + cyclophosphamide (CEF) adjuvant therapy for high-risk early breast cancer (BC): interim analysis of the FinXX-trial

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.82

2009

Volltextzugriff (PDF)

Docetaxel 100 versus 80 mg/m[sup]2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial

Annals of oncology, 2009-03, Vol.20 (3), p.595

2009

Volltextzugriff (PDF)

The FinXX trial: Safety results in 600 patients (pts) randomized to either docetaxel (T) followed by cyclophosphamide (C) + epirubicin (E) + 5-FU (F) (CEF) or T + capecitabine (X) followed by CEX as adjuvant therapy for early breast cancer (BC)

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.11035-11035

2007

Volltextzugriff (PDF)

Phase III, randomized study of docetaxel (T) + capecitabine (X) (TX) followed by cyclophosphamide (C) + epirubicin (E) + X (CEX) vs. T followed by C + E + fluorouracil (F) (CEF) as adjuvant treatment for patients (pts) with early breast cancer (BC): An interim safety analysis

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.719-719

2005

Volltextzugriff (PDF)

Combination Chemotherapy with Dacarbazine and Lomustine in Disseminated Malignant Melanoma

Acta Radiologica: Oncology, 1986, Vol.25 (3), p.177-179

1986

Volltextzugriff (PDF)

Serum Creatine Kinase and Lactate Dehydrogenase during Cardiac Irradiation

Acta Medica Scandinavica, 1987-01, Vol.222 (3), p.247-250

1987

Volltextzugriff (PDF)

459 Weekly paclitaxel: an effective and well tolerated treatment for advanced breast cancer

European journal of cancer supplements, 2003-09, Vol.1 (5), p.S140-S140

2003

Volltextzugriff (PDF)

A flow cytometric analysis of 23 carcinoid tumors

Cancer, 1988-06, Vol.61 (12), p.2517-2520

1988

Volltextzugriff (PDF)

Glucose Uptake and Perfusion in Subcutaneous and Visceral Adipose Tissue during Insulin Stimulation in Nonobese and Obese Humans

The journal of clinical endocrinology and metabolism, 2002-08, Vol.87 (8), p.3902-3910

2002

Volltextzugriff (PDF)

Personalizing health care: feasibility and future implications

BMC medicine, 2013-08, Vol.11 (1), p.179-179, Article 179

2013

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(29)

Publikationsform

Sprache

Englisch
(36)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(20)
Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Biological And Medical Sciences
(14)
Female
(14)
Middle Aged
(14)
Medical Sciences
(13)
Adult
(11)
Male
(11)
Aged
(8)
Oncology
(7)
Breast Neoplasms - Drug Therapy
(5)
General & Internal Medicine
(5)
Medicine, General & Internal
(5)
Metabolic Diseases
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)
Breast Cancer
(4)
Breast Neoplasms - Pathology
(4)
Medicin Och Hälsovetenskap
(4)
Pharmacology. Drug Treatments
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The impact of short daily and nocturnal hemodialysis on quality of life, cardiovascular risk and survival

Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer

Docetaxel versus docetaxel alternating with gemcitabine as treatments of advanced breast cancer: final analysis of a randomised trial

2-weekly versus 3-weekly docetaxel to treat castration-resistant advanced prostate cancer: a randomised, phase 3 trial

Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

Two haemodialysis patients with epoetin alfa-induced pure red-cell aplasia recovered despite treatment with another epoetin preparation

Docetaxel 100 versus 80 mg/m2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial

S24 Update of the FINHER trial based on 5 years of follow-up

A diver unconscious after gastroenteritis

Amino acid uptake in the skeletal muscle measured using [11C]methylaminoisobutyrate (MEAIB) and PET

Epirubicin/docetaxel regimen in progressive breast cancer—a phase II study

Triweekly docetaxel versus biweekly docetaxel as a treatment for advanced castration resistant prostate cancer: Quality of life analysis

4019 POSTER Phase III, randomized, open-label study of triweekly docetaxel (tT) vs. biweekly docetaxel (bT) as treatment for advanced hormone refractory prostate cancer (HRPC): findings from an interim safety analysis

Phase III, randomized, open-label study of triweekly docetaxel versus biweekly docetaxel as treatments for advanced hormone-refractory prostate cancer: Findings from an interim safety analysis of the Finnish Uro-oncological Group Study 1-2003

Delayed diagnosis and large size of breast cancer after a false negative mammogram

Significant improvement in recurrence-free survival (RFS) when capecitabine (X) is integrated into docetaxel (T) → 5-FU + epirubicin + cyclophosphamide (CEF) adjuvant therapy for high-risk early breast cancer (BC): interim analysis of the FinXX-trial

Docetaxel 100 versus 80 mg/m[sup]2 as adjuvant treatments of early breast cancer: an exploratory analysis of a randomised trial

The FinXX trial: Safety results in 600 patients (pts) randomized to either docetaxel (T) followed by cyclophosphamide (C) + epirubicin (E) + 5-FU (F) (CEF) or T + capecitabine (X) followed by CEX as adjuvant therapy for early breast cancer (BC)

Phase III, randomized study of docetaxel (T) + capecitabine (X) (TX) followed by cyclophosphamide (C) + epirubicin (E) + X (CEX) vs. T followed by C + E + fluorouracil (F) (CEF) as adjuvant treatment for patients (pts) with early breast cancer (BC): An interim safety analysis

Combination Chemotherapy with Dacarbazine and Lomustine in Disseminated Malignant Melanoma

Serum Creatine Kinase and Lactate Dehydrogenase during Cardiac Irradiation

459 Weekly paclitaxel: an effective and well tolerated treatment for advanced breast cancer

A flow cytometric analysis of 23 carcinoid tumors

Glucose Uptake and Perfusion in Subcutaneous and Visceral Adipose Tissue during Insulin Stimulation in Nonobese and Obese Humans

Personalizing health care: feasibility and future implications

Suchergebnisse filtern